{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Bisantrene",
  "nciThesaurus": {
    "casRegistry": "78186-34-2",
    "chebiId": "",
    "chemicalFormula": "C22H22N8",
    "definition": "An anthracenyl bishydrazone with antineoplastic activity. Bisantrene intercalates with and disrupts the configuration of DNA, resulting in DNA single-strand breaks, DNA-protein crosslinking, and inhibition of DNA replication.  This agent is similar to doxorubicin in activity, but unlike doxorubicin, does not exhibit cardiotoxicity.",
    "fdaUniiCode": "39C34M111K",
    "identifier": "C1019",
    "preferredName": "Bisantrene",
    "semanticType": "Antibiotic",
    "subclassOf": [
      "C253"
    ],
    "synonyms": [
      "9,10-Anthracenedicarboxakdehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone]",
      "9,10-Anthracenedicarboxaldehyde Bis(2-imidazolin-2-yl)hydrazone",
      "BISANTRENE",
      "Bisantrene"
    ]
  }
}